Board MeetingBoard Meeting
Transgene Biotek's board approved Q1 FY27 standalone and consolidated results: revenue at ₹0.06 Cr, net loss at ₹0.39 Cr.
Transgene Biotek Ltd526139 · Filed with the exchange
They also extended the AGM date and appointed M/s. Manisha Dubey & Associates as new Internal Auditors for FY26-27.
No comments yet. Be the first.